EGFR and colorectal carcinoma: To investigate whether inhibition of PIR enhances the therapeutic effect of cetuximab (EGFR mAb, a standard approach in clinical CRC treatment) on CRC, we created CT26 cell‐based allograft model in BALB/c mice.